Plus, the U.S. set another record daily average of new coronavirus cases, Merck and 3M delivered earnings beats, Las Vegas Sands is considering a sale of its U.S. properties, and Tiffany and LVMH are in indirect discussions about a possible settlement.
Read MorePlus, the chances for stimulus being passed ahead of the election are looking evermore slim, Dunkin’ Brands shares are up on takeover reports, and Hasbro shares are down after the toy maker reported third quarter earnings.
Read MorePlus, the FDA officially approved Gilead’s remdesivir for treating hospitalized coronavirus patients, Intel share are down after reporting mixed earnings results, and things are looking like 2018 for bitcoin.
Read MorePlus, weekly jobless claims fell to their lowest level since March, Moderna has officially enrolled 30,000 participants in its late-stage COVID-19 vaccine trial, and Tesla delivered an earnings beat.
Read MoreMarket commentary seems to have shifted a bit to focus on the political theater – both whether a second set of stimulus programs will be reached before the upcoming election, or speculation about the election itself. The unrelenting focus on COVID-19 vaccines up to now seems to have faded a bit, even though the pandemic […]
Read MoreBuy Price: $17.00 or better Sell Price: TradersPro Sell Signal Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of immunotherapies and other cancer-targeting biologics. It develops CDX-1140, an agonist human monoclonal antibody, which is being studied as a single-agent and in combination with CDX-301 in a Phase I dose-escalation study in […]
Read MorePlus, stimulus negotiations are still going, Pfizer said it has set up its “biggest ever” logistics operation to distribute its COVID-19 vaccine candidate, and Nikola shares are up on hopes for its deal with GM.
Read MorePlus, today is do-or-die day for a stimulus deal before the election, Moderna’s CEO said it could have emergency use authorization from the FDA in December, and GM announced a $2.2 billion investment in manufacturing electric vehicles.
Read MorePlus, ConocoPhillips is buying Concho Resources, AMC shares are up after New York Gov. Cuomo says movie theaters in the state can reopen, and an analyst issued a prediction for presales for Apple’s new iPhone 12.
Read MorePlus, stimulus negotiations are making little progress, Boeing shares are up after Europe’s top aviation official said the 737 MAX could return to the skies in the region before the end of the year, and Navistar shares are up on reports that it has agreed to a deal to merge with Traton.
Read MorePlus, the tussle over a stimulus deal continues, Morgan Stanley delivered an earnings beat, and Fastly shares plummet after delivering downbeat third-quarter guidance.
Read MorePlus, Delta reported a $5.4 billion loss, AMC said it could run out of money by early 2021 as movie theaters continue struggle amid the ongoing coronavirus, and Disney announced a reorganization to focus its media and entertainment business on streaming.
Read MoreEver since coronavirus found its way to American shores, a large amount of media attention has been given to the Healthcare sector – and especially to the Biotechnology industry, where many of the biggest names across the world have been working hard to develop effective treatments for the disease. From the market’s bearish low in […]
Read MoreBuy Price: $5.00 or better Sell Price: TradersPro Sell Signal InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in the Germany and United States. Its C5a is an inflammatory mediator that is involved in the enhancement of a variety of autoimmune and other inflammatory diseases.
Read MorePlus, there’s more confusion on the stimulus front, GE got a big upgrade from Goldman Sachs, and Disney’s newest Pixar film is skipping theaters.
Read More